IO Biotech, Inc. (IOBT) Social Stream



IO Biotech, Inc. (IOBT): $1.38

0.02 (-1.43%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add IOBT to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#119 of 362

in industry

IO BIOTECH INC (IOBT) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering IOBT.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-06 3 $21 $20 $20.5 $1.9 978.95%
2022-10-12 3 $20 $15 $17.5 $1.9 821.05%
2022-11-14 4 $20 $15 $17.5 $1.9 821.05%
2022-11-21 4 $20 $10 $15 $1.9 689.47%
2023-03-20 4 $20 $10 $13.666 $1.9 619.26%
2023-05-12 4 $11 $10 $10.333 $1.9 443.84%
2023-05-25 4 $12 $11 $11.333 $1.9 496.47%
2023-08-14 4 $10 $7 $8.333 $1.9 338.58%
2023-11-14 5 $10 $7 $8.75 $1.9 360.53%
NA 2 $NA $NA $NA $1.9 NA%

The Trend in the Analyst Price Target


Over the past 52 weeks, IOBT's average price target has gone down $8.75.

Over the past 42 weeks, IOBT's average upside potential has been 520.72%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-24 4 20 10 13.666 2.87 376.17%
2023-03-15 4 20 10 13.666 2.25 507.38%
2023-03-17 4 20 10 13.666 1.98 590.2%
2023-05-25 4 12 11 11.333 2.01 463.83%
2023-09-28 5 10 7 8.750 1.33 557.89%

IOBT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


IOBT's average broker recommendation rating improved by 0.33 over the prior 24 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, IO BIOTECH INC's upside potential (average analyst target price relative to current price) is higher than 1041.22% of them.
  • IOBT has a higher number of analysts covering the stock than 138.44% of all US stocks.
  • IOBT has a higher average analyst price target than 174.95% of all US stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, IO BIOTECH INC's variance in analysts' estimates is lower than -135.11% of them.

Stocks similar to IO BIOTECH INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are MYNZ, DERM, and BNOX.

Is IOBT a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!